This #GUTRecentAdvancesInBasicScience review synthesises emerging evidence linking the microbiome to cardiovascular disease, highlighting shared inflammatory and metabolic pathways. Fusco et al. present Gut microbiota and atherosclerosis access it TMAO: Why It Increases & Factors That May Reduce TMAO levels SelfDecode Labs PDF] Trimethylamine N Oxide, the Microbiome, and Heart and Kidney Disease. Semantic Scholar Dietary bioactive ingredients to modulate the gut microbiota derived metabolite TMAO. New opportunities for functional food development Food & Function (RSC Publishing) DOI:10.1039 D0FO01237H Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target The role of trimethylamine N oxide as a mediator of cardiovascular complications in chronic kidney disease Kidney International